API

Active Pharmaceutical Ingredients (API)

At Dr. Ashleys, we specialize in the development, distribution, and supply of both complex and generic Active Pharmaceutical Ingredients (APIs). Our API business is a cornerstone of our pharmaceutical operations, reflecting our unwavering commitment to excellence in the industry. Our state-of-the-art Research and Development center is the heart of our innovation. Here, we focus on developing and optimizing cutting-edge process technologies essential for manufacturing APIs across a wide range of therapeutic categories. We pride ourselves on maintaining a comprehensive impurity portfolio, ensuring a prompt and reliable supply of high-quality APIs. Our deep understanding of the pharmaceutical industry’s stringent quality demands drives us to consistently meet and exceed expectations.

API Market

The API market, reported by Grand View Research, was estimated at $255 Billion in 2024 with market growth trajectory to reach $839 Billion by 2033. As the global population continues to age and the growing prevalence of chronic diseases such as cancer, cardiovascular disease, diabetes as well as acute respiratory and GI infections, the global demand for API’s will continue to grow at a rapid pace.

Although, the North America dominates upwards of 35% of the market, Asia Pacific is experiencing the fastest growth in the API market, supported by rising deposable incomes, increasing urbanization and a growing middle class. Other regions such as Europe will also command a growing share of the API trajectory market of $839 Billion.

Dr. Ashleys is the leader of API’s in Asia Pacific and European markets as well as Latin America and Africa. As soon as our 86,00 SQF Research & Development Center adjacent to our new 156,000 sf state-of-the-art pharmaceutical European manufacturing facility becomes fully operational in 2026, Dr. Ashleys will continue to expand its global leadership role in the manufacturing and distribution of API’s.

Anti-cancer APIs

Respiratory Diseases

Malaria

Cardiovascular Health

Why Dr. Ashleys?

  • Market Leadership – At Dr. Ashleys we are committed to delivering exceptional services, establishing ourselves as the market leader in pharmaceutical contract manufacturing. Our influence extends globally, reflecting our dedication to excellence.

  • A Diverse Product Portfolio – Our extensive product portfolio includes over 85 specialized pharmaceutical offerings, such as Tablets, Capsules, Liquid, Dry Syrups, and Ointments, covering both Beta and non-beta sections. This diversity ensures we meet the varied needs of the pharmaceutical industry.
  • Experienced Professionals – Our success is driven by our highly competent team of professionals, who are experts in pharmaceutics. They ensure the timely execution of projects with a competitive edge.
  • Uncompromising Quality – Quality is paramount at Dr. Ashleys. We ensure that our partners possess the necessary food or drug licenses and comply with FDA GMP-WHO and ISO certifications. This unwavering commitment to quality makes us a reliable and trustworthy source for a wide range of pharmaceutical ingredients.
  • Innovation and Expansion – At Dr. Ashleys, we continuously evolve, innovate, and expand our reach to meet the ever-changing demands of the pharmaceutical and nutraceutical landscape. We are dedicated to being your preferred partner in sourcing essential pharmaceutical solutions ensuring access to high-quality products that contribute to a healthier world.